Logo image of AZYO

AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Price, Quote, News and Overview

NASDAQ:AZYO - Nasdaq - US05479K1060 - Common Stock - Currency: USD

1.49  +0.03 (+2.05%)

AZYO Quote, Performance and Key Statistics

AZIYO BIOLOGICS INC-CLASS A

NASDAQ:AZYO (9/6/2023, 8:00:01 PM)

1.49

+0.03 (+2.05%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High9.01
52 Week Low1.1
Market Cap24.21M
Shares16.25M
Float6.05M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)11-13 2023-11-13/amc
IPO10-08 2020-10-08


AZYO short term performance overview.The bars show the price performance of AZYO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

AZYO long term performance overview.The bars show the price performance of AZYO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of AZYO is 1.49 USD. In the past month the price decreased by -1.97%. In the past year, price decreased by -79.62%.

AZIYO BIOLOGICS INC-CLASS A / AZYO Daily stock chart

AZYO Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About AZYO

Company Profile

AZYO logo image Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.

Company Info

AZIYO BIOLOGICS INC-CLASS A

12510 Prosperity Drive, Suite 370

Silver Spring MARYLAND 20904 US

CEO: Ronald Lloyd

Employees: 151

Company Website: https://www.aziyo.com/

Phone: 12402471143.0

AZIYO BIOLOGICS INC-CLASS A / AZYO FAQ

What is the stock price of AZIYO BIOLOGICS INC-CLASS A today?

The current stock price of AZYO is 1.49 USD. The price increased by 2.05% in the last trading session.


What is the ticker symbol for AZIYO BIOLOGICS INC-CLASS A stock?

The exchange symbol of AZIYO BIOLOGICS INC-CLASS A is AZYO and it is listed on the Nasdaq exchange.


On which exchange is AZYO stock listed?

AZYO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for AZIYO BIOLOGICS INC-CLASS A stock?

7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49. Check the AZIYO BIOLOGICS INC-CLASS A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AZIYO BIOLOGICS INC-CLASS A worth?

AZIYO BIOLOGICS INC-CLASS A (AZYO) has a market capitalization of 24.21M USD. This makes AZYO a Nano Cap stock.


How many employees does AZIYO BIOLOGICS INC-CLASS A have?

AZIYO BIOLOGICS INC-CLASS A (AZYO) currently has 151 employees.


What are the support and resistance levels for AZIYO BIOLOGICS INC-CLASS A (AZYO) stock?

AZIYO BIOLOGICS INC-CLASS A (AZYO) has a support level at 1.37 and a resistance level at 1.62. Check the full technical report for a detailed analysis of AZYO support and resistance levels.


Is AZIYO BIOLOGICS INC-CLASS A (AZYO) expected to grow?

The Revenue of AZIYO BIOLOGICS INC-CLASS A (AZYO) is expected to decline by -12.95% in the next year. Check the estimates tab for more information on the AZYO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AZIYO BIOLOGICS INC-CLASS A (AZYO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AZIYO BIOLOGICS INC-CLASS A (AZYO) stock pay dividends?

AZYO does not pay a dividend.


When does AZIYO BIOLOGICS INC-CLASS A (AZYO) report earnings?

AZIYO BIOLOGICS INC-CLASS A (AZYO) will report earnings on 2023-11-13, after the market close.


What is the Price/Earnings (PE) ratio of AZIYO BIOLOGICS INC-CLASS A (AZYO)?

AZIYO BIOLOGICS INC-CLASS A (AZYO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.25).


AZYO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AZYO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AZYO. AZYO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AZYO Financial Highlights

Over the last trailing twelve months AZYO reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 22.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%5.8%
Sales Q2Q%-18.53%
EPS 1Y (TTM)22.95%
Revenue 1Y (TTM)4.13%

AZYO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to AZYO. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 9.47% and a revenue growth -12.95% for AZYO


Ownership
Inst Owners74.28%
Ins Owners3.94%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.86
Price Target8.16 (447.65%)
EPS Next Y9.47%
Revenue Next Year-12.95%